What is ECHINAGREEN™?
ECHINAGREEN™ is a standardized complex of three diverse ingredients derived from two species of coneflower and different parts of these plants (herb, root).
Specifications
The sum of all components of the ECHINAGREEN™ complex includes the following groups of compounds:
- Echinacea purpurea herb standardization – 2% cichoric acid
- Echinacea purpurea root standardization – 1% cichoric acid
- Echinacea angustifolia root standardization – 4% echinacoside
Echinacea purpurea which we use as a raw material is cultivated in Poland in accordance with the Code of Good Practice (GACP) which means the product full traceability and consistent quality. In combination with harvesting period, it gives us the highest content of polyphenols including cichoric acid. Echinacea angustifolia which we use in complex is confirmed European origin. We use a technology based on aqueous extraction, vacuum evaporation and drying – thanks to which we obtain very pure, concentrated extract with high levels of active substances.
Warnings and precautions of use
Hypersensitivity to the active substance(s) and to other plants of the Asteraceae (Compositae) family.
What makes ECHINAGREEN™ unique?
The main indication for Echinacea from traditional use is the prevention and/or treatment of upper respiratory tract infections. Numerous literature reports indicate antiviral, antibacterial, antifungal, immunomodulatory, anti-inflammatory or antioxidant effects of the plant, exerted by caffeic acid derivatives (cichoric acid, echinacoside), polysaccharides, glycoproteins, alkamides present in its composition.
Immunostimulatory activity
A thorough review and meta-analysis was performed evaluating the effect of coneflower on the incidence and duration of the common cold. Fourteen unique studies were included in the meta-analysis. Echinacea reduced the risk of developing a cold by 58% and the duration of a cold by 1.25 days.
Anti-inflammatory activity
The main indication for Echinacea from traditional use is the prevention and/or treatment of upper respiratory tract infections. Numerous literature reports indicate antiviral, antibacterial, antifungal, immunomodulatory, anti-inflammatory or antioxidant effects of the plant, exerted by caffeic acid derivatives (cichoric acid, echinacoside), polysaccharides, glycoproteins, alkamides present in its composition.
Antiviral effects
Aqueous extracts of aerial parts, stems, leaves and flowers and aqueous extracts of E. purpurea root have been shown to have significant activity against influenza virus and herpes simplex virus (HSV-1).